Abstract
The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis. Here, we applied mass spectrometry imaging (MSI) to acquire and visualize the molecular profiles at the single-cell and subcellular levels of 14 different breast cancer cell lines. We built a molecular library of genetically well-characterized cell lines. Multistep processing, including deep learning, resulted in a breast cancer subtype, the cancer's hormone status, and a genotypic recognition model based on metabolic phenotypes with cross-validation rates of up to 97%. Moreover, we applied our single-cell-based recognition models to complex tissue samples, identifying cell subtypes in tissue context within seconds during measurement. These data demonstrate "on the spot" digital pathology at the single-cell level using MSI, and they provide a framework for fast and accurate high spatial resolution diagnostics and prognostics.
| Original language | English |
|---|---|
| Pages (from-to) | 6180-6190 |
| Number of pages | 11 |
| Journal | Analytical Chemistry |
| Volume | 94 |
| Issue number | 16 |
| Early online date | 12 Apr 2022 |
| DOIs | |
| Publication status | Published - 26 Apr 2022 |
Keywords
- HER2 STATUS
- NEOADJUVANT CHEMOTHERAPY
Fingerprint
Dive into the research topics of ''On the Spot' Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver